Lee, J.S.; Yost, S.E.; Li, S.M.; Cui, Y.; Frankel, P.H.; Yuan, Y.-C.; Schmolze, D.; Egelston, C.A.; Guo, W.; Murga, M.;
et al. Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers 2022, 14, 3159.
https://doi.org/10.3390/cancers14133159
AMA Style
Lee JS, Yost SE, Li SM, Cui Y, Frankel PH, Yuan Y-C, Schmolze D, Egelston CA, Guo W, Murga M,
et al. Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers. 2022; 14(13):3159.
https://doi.org/10.3390/cancers14133159
Chicago/Turabian Style
Lee, Jin Sun, Susan E. Yost, Sierra Min Li, Yujie Cui, Paul H. Frankel, Yate-Ching Yuan, Daniel Schmolze, Colt A. Egelston, Weihua Guo, Mireya Murga,
and et al. 2022. "Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer" Cancers 14, no. 13: 3159.
https://doi.org/10.3390/cancers14133159
APA Style
Lee, J. S., Yost, S. E., Li, S. M., Cui, Y., Frankel, P. H., Yuan, Y.-C., Schmolze, D., Egelston, C. A., Guo, W., Murga, M., Chang, H., Bosserman, L., & Yuan, Y.
(2022). Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers, 14(13), 3159.
https://doi.org/10.3390/cancers14133159